Covid-19 roundup: Oxford vaccine scientist says overblown safety fears caused death of 'hundreds of thousands'; Omicron-specific booster may not provide more protection — report
A vaccine booster targeting Omicron may not provide more protection against the variant compared to a booster shot of Moderna’s newly-FDA approved Covid-19 vaccine, according to a preprint from NIAID and a report from STAT.
The NIH’s National Institute of Allergy and Infectious Diseases conducted the study in primates, comparing Moderna’s licensed vaccine — mRNA-1273 — and Moderna’s experimental booster shot for the Omicron variant, known as mRNA-1273.529. When the scientists studied blood samples from the animals, immune responses in the different groups were not majorly different, regardless of the shot the animals received.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
